Diabetes Therapy is an international, open access, rapid publication (peer review in 2 weeks, published 3-4 weeks from acceptance), peer-reviewed journal focused on cutting-edge research in the prevention, treatment, management, and education of diabetes and related disorders including obesity and metabolic syndromes. The journal is of interest to a broad audience of pharmaceutical and healthcare professionals and publishes original research papers, drug reviews, case reports, and short communications. Each paper is accompanied by a bulleted slide summary to give a time-efficient overview of the content. All submissions have the option to include slide sets, video components, animations, and/or interactive case studies.Diabetes Therapy is published under the Creative Commons Attribution-Noncommercial License, which allows users to read, copy, distribute, and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited. The author assigns the exclusive right to any commercial use of the article to Springer. For more information about the Creative Commons Attribution-Noncommercial License, click here: http://creativecommons.org/licenses/by-nc/2.5
4 Volumes 8 Issues 89 Articles available from 2010 - 2013Browse Volumes & Issues
The SGLT2 Inhibitor Empagliflozin for the Treatment of Type 2 Diabetes Mellitus: a Bench to Bedside Review
Janet B. McGill (April 2014)
- Journal Title
- Diabetes Therapy
- Open Access
- Available under Open Access This content is freely available online to anyone, anywhere at any time.
- Volume 1 / 2010 - Volume 4 / 2013
- Print ISSN
- Online ISSN
- Springer Healthcare
- Additional Links
To view the rest of this content please follow the download PDF link above.